WS12.1 An exploratory study to determine the impact of lumacaftor/ivacaftor (LUM/IVA) on disease progression in children 2 through 5 years of age with cystic fibrosis homozygous for F508del-CFTR (F/F)
Title:
WS12.1 An exploratory study to determine the impact of lumacaftor/ivacaftor (LUM/IVA) on disease progression in children 2 through 5 years of age with cystic fibrosis homozygous for F508del-CFTR (F/F)
Author:
Stahl, M. Roehmel, J. Eichinger, M. Doellinger, F. Naehrlich, L. Kopp, M.V. Dittrich, A.-M. Lee, C. Sommerburg, O. Tian, S. Xu, T. Wu, P. Joshi, A. Duncan, M. Wielpütz, M.O. Mall, M.
Appeared in:
Journal of cystic fibrosis
Paging:
Volume 20 () nr. S1 pages S22-S23
Year:
2021
Contents:
Publisher:
European Cystic Fibrosis Society. All rights reserved.